Ameliorating effects of Acanthopanax koreanum extract and components on nicotine dependence and withdrawal symptoms
Addiction Biology · 2024
DOI: 10.1111/adb.13360 ↗At a glance
Journal article in Addiction Biology, 2024. Written by Hyun Jun Lee and 5 co-authors. Institution: Uimyung Research Institute for Neuroscience, Department of Pharmacy, Sahmyook University, Seoul, Republic of Korea. Major MEDLINE topics: Tobacco Use Disorder, Eleutherococcus, Substance Withdrawal Syndrome. Cited 1 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Ministry of Food and Drug Safety, National Research Foundation of Korea.
Abstract (original language)
Tobacco smoking is a serious health problem in society. While smoking rates are declining, smoking remains a serious risk to national health. Currently, there are several medications available to aid in smoking cessation. However, these medications have the disadvantages of low success rates in smoking cessation and various side effects. Therefore, natural‐based smoking cessation aids are being suggested as a good alternative due to their accessibility and minimal side effects. The roots and stems of Acanthopanax koreanum (AK) Nakai, a plant that is native to Jeju Island, South Korea, have traditionally been used as tonic and sedatives. Moreover, eleutheroside B and chlorogenic acid are the main components of AK stem extract. In the present study, we investigated the effect of 70% ethanol AK extract and its components on ameliorating nicotine dependence and withdrawal symptoms by using behavioural tests in mice. In addition, alterations in the dopaminergic and DRD1‐EPAC‐ERK‐CREB pathways were observed using dopamine ELISA and western blotting using mouse brains. Our findings demonstrate that the AK extract and its components effectively mitigated the effects of nicotine treatment in behavioural tests. Furthermore, it normalized the dopamine concentration and the expression level of nicotine acetylcholine receptor α7. Additionally, it was observed that AK extract and its components led to the normalization of DRD1, ERK and CREB expression levels. These results indicate that AK extract exhibits effects in ameliorating nicotine dependence behaviour and alleviating withdrawal symptoms. Moreover, EB and CGA are considered potential marker components of AK extract.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Uimyung Research Institute for Neuroscience, Department of Pharmacy, Sahmyook University, Seoul, Republic of Korea.
- Department of Chemistry & Life Science, Sahmyook University, Seoul, Republic of Korea.
- School of Pharmacy, Jeonbuk National University, Jeonju, Republic of Korea.
ORCID profiles: Hee Jin Kim
Funding
- Ministry of Food and Drug Safety
- National Research Foundation of Korea
Cite
APA
Lee, H. J., Ortiz, D. M., Sayson, L. V., Kim, M., Cheong, J. H., & Kim, H. J. (2024). Ameliorating effects of Acanthopanax koreanum extract and components on nicotine dependence and withdrawal symptoms. Addiction Biology. https://doi.org/10.1111/adb.13360
Vancouver
Lee HJ, Ortiz DM, Sayson LV, Kim M, Cheong JH, Kim HJ. Ameliorating effects of Acanthopanax koreanum extract and components on nicotine dependence and withdrawal symptoms. Addiction Biology. 2024. doi:10.1111/adb.13360
BibTeX
@article{Lee2024,
author = {Lee, Hyun Jun and Ortiz, Darlene Mae and Sayson, Leandro Val and Kim, Mikyung and Cheong, Jae Hoon and Kim, Hee Jin},
title = {Ameliorating effects of Acanthopanax koreanum extract and components on nicotine dependence and withdrawal symptoms},
journal = {Addiction Biology},
year = {2024},
doi = {10.1111/adb.13360}
}
EUVIMED